Starter en tråd om Oncopeptides AB (ONCO.ST) siden en del har den i favoritt-listen eller i porteføljen sin 
Oncopeptides AB (publ), a clinical development pharmaceutical company, develops anti-cancer drugs. It develops Ygalo, a cytotoxic therapy that is in late-stage development use for the treatment of multiple myeloma.
The company was founded in 2000 and is headquartered in Stockholm, Sweden.
La oss starte diskusjonen! @etisk @babyrage @Aksjer888 @Dormancy @anlpau @BioMed @kyrredyr @pdx